Artelo Biosciences, Inc.
ARTL
$5.98
-$0.21-3.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.67M | -13.47M | -12.88M | -12.49M | -10.50M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 262.00K | 295.00K | 208.00K | 137.00K | 54.00K |
| Total Other Non-Cash Items | 3.13M | 2.75M | 2.40M | 901.00K | 689.00K |
| Change in Net Operating Assets | -3.36M | 2.30M | 1.75M | 3.28M | 4.30M |
| Cash from Operations | -12.63M | -8.11M | -8.52M | -8.18M | -5.46M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.00K | -62.00K | -62.00K | 250.00K | 4.75M |
| Cash from Investing | -62.00K | -62.00K | -62.00K | 250.00K | 4.75M |
| Total Debt Issued | 464.00K | 1.20M | 608.00K | 737.00K | 737.00K |
| Total Debt Repaid | -1.27M | -24.00K | -24.00K | -- | -- |
| Issuance of Common Stock | 15.65M | 16.55M | 6.28M | 4.58M | 1.14M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.85M | 17.73M | 6.87M | 5.32M | 1.87M |
| Foreign Exchange rate Adjustments | -20.00K | -24.00K | -23.00K | -28.00K | 18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.13M | 9.53M | -1.74M | -2.64M | 1.19M |